YSG:NYSEYatsen Holding Limited Analysis
Data as of 2026-09-02 - not real-time
$2.66
Latest Price
9/10Risk
Risk Level: High
Executive Summary
Yatsen Holding Limited is priced at $2.66 and its moving averages line up in bearish order, the shorter trailing the longer. It has lost 23.8% over the past 30 days. Relative strength is 29.9 — oversold — and the MACD signal is bearish. Price has been bracketed by support at $2.65 and resistance at $3.49.
Multiples put this in undervalued territory at a P/E of 5.9. Analyst price targets sit 51.7% above the current price. Revenue is growing at 22.5% on a -3.0% profit margin.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 58.6%, a beta of 1.29 and a maximum drawdown of 79.3%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 3/10.
Multiples put this in undervalued territory at a P/E of 5.9. Analyst price targets sit 51.7% above the current price. Revenue is growing at 22.5% on a -3.0% profit margin.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 58.6%, a beta of 1.29 and a maximum drawdown of 79.3%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 3/10.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 2/10
Key Factors
- Short-term moving averages stacked below long-term ones
- RSI at 29.9 signals oversold conditions
- Trading below the 200-day average of 3.75
Medium Term
1–3 yearsNeutral
Model confidence: 1/10
Key Factors
- Short-term moving averages stacked below long-term ones
- RSI at 29.9 signals oversold conditions
- Trading below the 200-day average of 3.75
Long Term
> 3 yearsNeutral
Model confidence: 3/10
Key Factors
- Negative profit margin of -3.0%
- Analyst targets imply +51.7% versus the current price
- Negative return on equity of -4.9%
Key Metrics & Analysis
Financial Health
Revenue Growth22.50%
Profit Margin-3.03%
P/E Ratio5.9
ROE-4.94%
ROA-3.42%
Debt/Equity5.61
P/B Ratio0.6
Technical Analysis
TrendBearish
RSI29.9
Support$2.65
Resistance$3.49
MA 20$3.11
MA 50$3.29
MA 200$3.75
MACDBearish
VolumeStable
Fear & Greed Index92.25
Valuation
Target Price$4.04
Upside/Downside51.70%
GradeUndervalued
TypeBlend
Risk Assessment
Beta1.29
Volatility58.64%
Sector RiskLow
Reg. RiskMedium
Geo RiskHigh
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.